Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle S Mazei-Robison

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Neuropharmacology|October 11, 2005
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382AlaMichelle S Mazei-Robison, Randy D Blakely
Cold Spring Harbor Perspectives in Medicine|July 5, 2012
Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neuronsMichelle S Mazei-Robison, Eric J Nestler
Cold Spring Harbor Perspectives in Medicine|January 23, 2020
Opioid-Induced Molecular and Cellular Plasticity of Ventral Tegmental Area Dopamine NeuronsMarie A Doyle, Michelle S Mazei-Robison
Molecular Brain|February 10, 2019
Determination of circuit-specific morphological adaptations in ventral tegmental area dopamine neurons by chronic morphineSarah C Simmons, Katie Wheeler, Michelle S Mazei-Robison
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 22, 2017
Reward Circuitry in AddictionSarah Cooper, A J Robison, Michelle S Mazei-Robison
Molecular Pharmacology|May 17, 2005
Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulationMaureen K Hahn, Michelle S Mazei-Robison, Randy D Blakely
Neuroscience Letters|March 15, 2020
Serum- and glucocorticoid-inducible kinase 1 activity reduces dendritic spines in dorsal hippocampusEmily E Steffke, Deniz Kirca, Michelle S Mazei-Robison, et al.
Neuropharmacology|February 8, 2017
Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behaviorSophia Kaska, Rebecca Brunk, Vedrana Bali, et al.
Neuropharmacology|July 24, 2008
Neurotrophic factors and structural plasticity in addictionScott J Russo, Michelle S Mazei-Robison, Jessica L Ables, et al.
Biological Psychiatry|April 2, 2020
Can I Get a Witness? Using Vicarious Defeat Stress to Study Mood-Related Illnesses in Traditionally Understudied PopulationsBrandon L Warren, Michelle S Mazei-Robison, Alfred J Robison, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Neuropharmacology|October 11, 2005
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382AlaMichelle S Mazei-Robison, Randy D Blakely
Cold Spring Harbor Perspectives in Medicine|July 5, 2012
Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neuronsMichelle S Mazei-Robison, Eric J Nestler
Cold Spring Harbor Perspectives in Medicine|January 23, 2020
Opioid-Induced Molecular and Cellular Plasticity of Ventral Tegmental Area Dopamine NeuronsMarie A Doyle, Michelle S Mazei-Robison
Molecular Brain|February 10, 2019
Determination of circuit-specific morphological adaptations in ventral tegmental area dopamine neurons by chronic morphineSarah C Simmons, Katie Wheeler, Michelle S Mazei-Robison
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 22, 2017
Reward Circuitry in AddictionSarah Cooper, A J Robison, Michelle S Mazei-Robison
Molecular Pharmacology|May 17, 2005
Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulationMaureen K Hahn, Michelle S Mazei-Robison, Randy D Blakely
Neuroscience Letters|March 15, 2020
Serum- and glucocorticoid-inducible kinase 1 activity reduces dendritic spines in dorsal hippocampusEmily E Steffke, Deniz Kirca, Michelle S Mazei-Robison, et al.
Neuropharmacology|February 8, 2017
Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behaviorSophia Kaska, Rebecca Brunk, Vedrana Bali, et al.
Neuropharmacology|July 24, 2008
Neurotrophic factors and structural plasticity in addictionScott J Russo, Michelle S Mazei-Robison, Jessica L Ables, et al.
Biological Psychiatry|April 2, 2020
Can I Get a Witness? Using Vicarious Defeat Stress to Study Mood-Related Illnesses in Traditionally Understudied PopulationsBrandon L Warren, Michelle S Mazei-Robison, Alfred J Robison, et al.
Pageof 4